Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.1K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.8K
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

291
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
291
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

3.5K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
3.5K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Risk of bias and clinical benefit of phase III trials supporting FDA-approved anticancer medicines, 2018-2025: A cross-sectional analysis.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Electronic Modulation of Flexible Ether Oxygen-Based Covalent Organic Frameworks for Efficient Oxygen Reduction Reaction.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

A disulfide-bridged single-stranded DNA nanotube for co-delivery of siRNA and chemotherapeutics in ovarian cancer therapy.

Frontiers in medicine·2026
Same author

The stability of critical distance theory model for high cycle fatigue limit prediction of foreign object damaged blade samples.

Scientific reports·2026
Same author

The landscape for therapeutic cancer vaccines.

Nature reviews. Drug discovery·2026
Same author

Covalent Organic Framework with Tailored Angstrom-Scale Motifs for Efficient Water Activation and Desalination.

ACS applied materials & interfaces·2026

相关实验视频

Updated: Sep 18, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

MFE-DDI:用于药物相互作用预测的多视图特征编码框架.

Lingfeng Wang1, Yinghong Li1, Yaozheng Zhou1

  • 1Beijing University of Chemical Technology, Beijing, 100029, China.

Computational and structural biotechnology journal
|June 23, 2025
PubMed
概括

准确预测药物相互作用 (DDI) 对安全的组合疗法至关重要. 我们的新多视图特征嵌入 (MFE-DDI) 方法通过整合多种药物数据来增强DDI预测,优于现有的方法.

关键词:
深度学习是一种深度学习.药物相互作用 药物相互作用多视图药物特征 药物特征多视图多维特征融合的多维特征融合.

更多相关视频

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

相关实验视频

Last Updated: Sep 18, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

科学领域:

  • 计算化学是一种计算化学.
  • 药理学 药理学是指药理学的学科.
  • 生物信息学是一种生物信息学.

背景情况:

  • 多种药物联合治疗对于复杂疾病至关重要,但药物相互作用 (DDI) 可能是有害的.
  • 准确和快速的DDI预测对于患者安全和减轻药物不良反应至关重要.
  • 现有的计算方法通常依赖于单视图药物特征,限制了预测准确度.

研究的目的:

  • 开发一种先进的计算方法来预测药物相互作用 (DDI).
  • 通过整合多种药物特征表示来增强DDI预测.
  • 提高药物相互作用预测模型的准确性和稳定性.

主要方法:

  • 建议多视图特征嵌入用于药物相互作用预测 (MFE-DDI) 模型.
  • 整合多种药物数据来源:SMILES,分子图形和原子空间语义信息.
  • 使用基于注意力的融合模块,有效地结合多视图药物特征.

主要成果:

  • 在三个独立的数据集中,MFE-DDI显著超过了基线方法.
  • 模型分析证实了每个集成组件的稳定性和必要性.
  • 案例研究证明了MFE-DDI对新批准药物的实际有效性.

结论:

  • MFE-DDI模型为预测药物相互作用提供了一种强大而有效的方法.
  • 整合多视图药物特征可以提高DDI预测的准确性和可靠性.
  • 这种方法有望提高药物安全性和优化组合疗法.